Why Intel’s free-marketeer CEO Pat Gelsinger wants a government handout

WHO advises against using Gilead’s remdesivir to Deal with Hepatitis COVID Sufferers

The World Health Organization urged against using Gilead Sciences Inc.’s remdesivir to deal with hospitalized COVID-19 patients under a month later U.S. regulators given the medication a quick approval. “There is now no proof that it enhances the demand for venting,” a board of WHO-convened specialists creating COVID-19 treatment guidelines stated from The BMJ medical […]

An infrastructure deal looks likely, and that’s good news for these stocks

U.S. futures are gaining again on after Thursday’s record close on the S&P 500 and Nasdaq. Read More

Will vaccine mandates worsen the ongoing health care shortage?

More states are adopting vaccine mandates for health care workers, leaving the remaining unvaccinated, and hospitals already short staffed and filled with COVID patients, with limited options. Read More